PP_1170x120_10-25-21

erythromycin tablets

Amneal launches two generics

Amneal launches two generics

BRIDGEWATER, N.J. — Amneal Pharmaceuticals has launched two generic drugs, including first-to-market erythromycin tablets. The Amneal erythromycin product, in 250 mg and 500 mg strengths, is a therapeutic equivalent for the reference listed drug erythromycin tablets from Arbor Pharmaceuticals and is the only other immediate release oral tablet available. “Amneal is committed to increasing access to

Adheris Health